MILLENDO THERAPEUTICS, INC.

Profile

Company Names

MILLENDO THERAPEUTICS, INC.
ATTEROCOR, INC.

Addresses

301 NORTH MAIN STREET, SUITE 100, ANN ARBOR, MI 48104

820 HEATHERWAY, ANN ARBOR, MI 48104

Phone Numbers

(734) 845-9000
(734) 741-1683

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$106,513,245.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2017-12-19 
$50,043,201.00 
$59,109,960.00 
$9,066,759.00 
Equity 
3
2015-12-18 
$47,697,172.00 
$70,702,987.00 
$23,005,815.00 
Equity 
2
2012-07-25 
$8,522,872.00 
$16,633,013.00 
$8,110,141.00 
Equity 
1
2012-04-17 
$250,000.00 
$500,000.00 
$250,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THIERRY 
 
ABRIBAT 
DIRECTOR
JEFFERY 
 
BRINZA 
EXECUTIVE OFFICER
WILLIAM 
J. 
HARRINGTON 
DIRECTOR
MARY LYNNE 
 
HEDLEY 
DIRECTOR
JAMES 
 
HINDMAN 
DIRECTOR
RAILI 
 
KERPPOLA 
EXECUTIVE OFFICER
RAILI 
E. 
KERPPOLA 
EXECUTIVE OFFICER, DIRECTOR
PHARIS 
 
MOHIDEEN 
EXECUTIVE OFFICER
CAROLE 
 
NEUCHTERLEIN 
DIRECTOR
JULIA 
 
OWENS 
EXECUTIVE OFFICER, DIRECTOR
JULIA 
C. 
OWENS 
EXECUTIVE OFFICER, DIRECTOR
CHRISTOPHER 
 
SEITER 
EXECUTIVE OFFICER
RANDALL 
 
WHITCOMB 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-12-19 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-18 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-25 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-25 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-04-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK PARTNERS LLC